Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods
CJ Hoekstra, I Paglianiti, OS Hoekstra, EF Smit… - European journal of …, 2000 - Springer
[18 F]-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) is considered a
valuable tool in the diagnosis and staging of cancer. In addition, it seems promising as a …
valuable tool in the diagnosis and staging of cancer. In addition, it seems promising as a …
Positron emission tomography imaging in nonmalignant thoracic disorders
A Alavi, N Gupta, JL Alberini, M Hickeson… - Seminars in nuclear …, 2002 - Elsevier
The role of the fluorodeoxyglucose (FDG) technique positron emission tomography (PET) is
well established in the management of patients with lung cancer. Increasingly, it is becoming …
well established in the management of patients with lung cancer. Increasingly, it is becoming …
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal …
18F-FDG PET is often used in clinical routine for diagnosis, staging, and response to therapy
assessment or prediction. The standardized uptake value (SUV) in the primary or regional …
assessment or prediction. The standardized uptake value (SUV) in the primary or regional …
[PDF][PDF] Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
HA Wieder, BLDM Brucher… - Journal of Clinical …, 2004 - researchgate.net
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous
Cell Carcinoma and Response to Treatment Page 1 Time Course of Tumor Metabolic Activity …
Cell Carcinoma and Response to Treatment Page 1 Time Course of Tumor Metabolic Activity …
FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma
E Brun, E Kjellén, J Tennvall, T Ohlsson… - Head & …, 2002 - Wiley Online Library
Background Positron emission tomography (PET) provides metabolic information of tissues
in vivo. The purpose of this study was to assess the value of PET with 2‐[18 F] fluoro‐2 …
in vivo. The purpose of this study was to assess the value of PET with 2‐[18 F] fluoro‐2 …
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging
Glucose is the main metabolic substrate of the brain and its oxidation produces the amount
of energy that is necessary for adequate cerebral activity. The PET tracer 18F …
of energy that is necessary for adequate cerebral activity. The PET tracer 18F …
FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
JS Ryu, NC Choi, AJ Fischman, TJ Lynch, DJ Mathisen - Lung cancer, 2002 - Elsevier
This study was performed to investigate the utility of FDG–PET for:(1) initial staging, and (2)
restaging of the primary and mediastinal nodal lesions 2 weeks after the completion of …
restaging of the primary and mediastinal nodal lesions 2 weeks after the completion of …
PET/CT of esophageal cancer: its role in clinical management
JF Bruzzi, RF Munden, MT Truong, EM Marom… - Radiographics, 2007 - pubs.rsna.org
Positron emission tomography (PET)/computed tomography (CT) has important utility and
limitations in the initial staging of esophageal cancer, evaluation of response to neoadjuvant …
limitations in the initial staging of esophageal cancer, evaluation of response to neoadjuvant …
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology: Part II. The clinical value in detecting and staging primary tumours
I Ak, MPM Stokkel, EKJ Pauwels - Journal of cancer research and clinical …, 2000 - Springer
Abstract The tumoral uptake of 2-[18 F] fluoro-2-deoxy-D-glucose (18 FdGlc) is based upon
enhanced glycolysis. Positron-emission tomography (PET) using 18 FdGlc provides the …
enhanced glycolysis. Positron-emission tomography (PET) using 18 FdGlc provides the …
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable …
M van Heijl, JM Omloo… - Annals of …, 2011 - journals.lww.com
Background: Neoadjuvant chemoradiotherapy before surgery can improve survival in
patients with potentially curable esophageal cancer, but not all patients respond …
patients with potentially curable esophageal cancer, but not all patients respond …